The price-to-earnings ratio for Incyte Corp (NASDAQ: INCY) is above average at 213.86x. The 36-month beta value for INCY is also noteworthy at 0.69. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 2 rating it as “overweight,” 16 rating it as “hold,” and 0 rating it as “sell.”
The public float for INCY is 190.50M, and at present, short sellers hold a 3.77% of that float. The average trading volume of INCY on April 24, 2025 was 1.97M shares.
INCY) stock’s latest price update
The stock price of Incyte Corp (NASDAQ: INCY) has jumped by 1.08 compared to previous close of 57.38. Despite this, the company has seen a fall of -0.79% in its stock price over the last five trading days. zacks.com reported 2025-04-23 that INCY is likely to beat Q1 earnings estimates, primarily driven by increased U.S. sales and royalties from Novartis on ex-U.S. sales of its lead drug, Jakafi.
INCY’s Market Performance
INCY’s stock has fallen by -0.79% in the past week, with a monthly drop of -7.61% and a quarterly drop of -19.90%. The volatility ratio for the week is 2.84% while the volatility levels for the last 30 days are 4.13% for Incyte Corp The simple moving average for the last 20 days is -1.97% for INCY’s stock, with a simple moving average of -14.27% for the last 200 days.
Analysts’ Opinion of INCY
UBS gave a rating of “Neutral” to INCY, setting the target price at $77 in the report published on December 17th of the previous year.
INCY Trading at -10.39% from the 50-Day Moving Average
After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.91% of loss for the given period.
Volatility was left at 4.13%, however, over the last 30 days, the volatility rate increased by 2.84%, as shares sank -6.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.08% lower at present.
During the last 5 trading sessions, INCY fell by -0.79%, which changed the moving average for the period of 200-days by +1.17% in comparison to the 20-day moving average, which settled at $59.17. In addition, Incyte Corp saw -16.03% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INCY starting from Flannelly Barry P, who sale 19,807 shares at the price of $67.69 back on Mar 14 ’25. After this action, Flannelly Barry P now owns 33,567 shares of Incyte Corp, valued at $1,340,656 using the latest closing price.
BARRY FLANNELLY, the Officer of Incyte Corp, proposed sale 19,807 shares at $67.69 during a trade that took place back on Mar 14 ’25, which means that BARRY FLANNELLY is holding shares at $1,340,728 based on the most recent closing price.
Stock Fundamentals for INCY
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.92 for the gross margin
The net margin for Incyte Corp stands at 0.01. The total capital return value is set at 0.02. Equity return is now at value 0.76, with 0.53 for asset returns.
Based on Incyte Corp (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 7.7. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 27.31.
Currently, EBITDA for the company is 408.16 million with net debt to EBITDA at -6.23. When we switch over and look at the enterprise to sales, we see a ratio of 2.26. The receivables turnover for the company is 4.97for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.97.
Conclusion
In summary, Incyte Corp (INCY) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
